Southern Institute of Pharmaceutical Economics: It is predicted that various indicators of the pharmaceutical economy will slow down in 2015.
Lin Jianning, director of the Southern Institute of Pharmaceutical Economics, said at the 2015 China Pharmaceutical Industry Chain Health Wealth Forum last weekend that the operating environment of the pharmaceutical economy is still relatively cold this year. Under the circumstances that the GDP growth rate of the pharmaceutical industry is not less than 7%, the export growth rate is not less than 2014, and the financial investment in medical and health care is not less than 8%, it is predicted that various indicators will slow down in 2015, with the specific total output value increasing by 15% and sales revenue by 13%, industrial profits rose 11 percent.
He further said that China's exports of pharmaceutical products have also entered a period of medium and low growth. Affected by overcapacity, sluggish external demand, rising costs, and increased trade frictions, in 2014, my country's pharmaceutical products achieved exports of US $55 billion billion, a year-on-year increase of 7.38 percent, an increase of 0.6 percent over the same period last year, and the pharmaceutical trade surplus fell by 6% year-on-year.
According to the monitoring data of the Southern Institute, since the second half of 2013, the growth rate of the total output value of the pharmaceutical industry has continued to slow down. After 2014, the growth rate of the total output value of the pharmaceutical industry has been hovering at 15%-17%. In 2014, the total output value of the pharmaceutical industry reached 2579.8 billion billion yuan, up 15.7 percent year on year. It grew by 15.2 percent in the first quarter of 2015.